SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-20-275447
Filing Date
2020-10-23
Accepted
2020-10-23 16:05:54
Documents
3
Group Members
VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD.VIFOR PHARMA LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13G d91184dsc13g.htm SC 13G 91982
2 EX-99.(A) d91184dex99a.htm EX-99.(A) 977
3 EX-99.(B) d91184dex99b.htm EX-99.(B) 7843
  Complete submission text file 0001193125-20-275447.txt   102489
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Subject) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87880 | Film No.: 201257828
SIC: 2834 Pharmaceutical Preparations

Mailing Address RECHENSTRASSE 37 ST. GALLEN V8 9000
Business Address RECHENSTRASSE 37 ST. GALLEN V8 9000 41 58 851 80 00
Vifor (International) Ltd (Filed by) CIK: 0001675217 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G